Progression of peritoneal adenomucinosis to the scrotum: a rare occurrence treated with cytoreductive surgery and hyperthermic chemoperfusion of the scrotum in two patients
Article Sidebar
Main Article Content
Introduction: Disseminated Peritoneal Adenomucinosis (DPAM) is an infrequent presentation of appendiceal cancer. Infrequently, umbilical or inguinal hernias could be the first clinical manifestation of this condition; DPAM extension to the scrotum may be anatomically viable. Treatment with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is the standard of treatment for DPAM. We hypothesize that these same treatment principles, consisting of CRS with hyperthermic chemoperfusion of the scrotum (HCS), could be applied to the scrotal dissemination of DPAM.
Methods: We reviewed our Institution’s prospective cancer database and identified two cases of DPAM with extension to the scrotum. Their medical records were examined, and close follow-up was performed. Tumor histopathology and cytoreduction scores were evaluated. Tumor progression was monitored on follow-up by physical examination, tumor markers (CEA, CA 125, CA 19.9) and abdomino-pelvic CT scan.
Results: Two patients who previously had CRS/ HIPEC for DPAM were successfully treated with HSC. Both patients are alive and free of disease at 88 and 57 months following initial CRS/HIPEC, and 50 and 32 months following CRS/HCS, respectively.
Conclusion: Increased awareness by surgeons to the coexistence of inguinal hernia with peritoneal neoplasm and the need for a surgical repair is raised. CRS/HCS may be employed to treat patients with DPAM extension to the scrotum. Successful outcome is dependent on complete cytoreduction of metastatic tumor.
- Hyperthermic chemoperfusion
- scrotum
- DPAM
- cytoreductive surgery
- CRS
- HIPEC
Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features,site of origin, prognosis, and relationship to “pseudomyxoma peritonei”. Am J Surg Pathol. 1995; 19(12): 1390–408. DOI: https://doi.org/10.1097/00000478-199512000-00006
Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012; 30: 2449–56. DOI: https://doi.org/10.1200/jco.2012.30.4_suppl.532
Mohamed F, Cecil T, Moran B, Sugarbaker PH. A new standard of care for the management of peritoneal surface malignancy. Curr Oncol. 2011; 18(2): e84–e96. DOI: https://doi.org/10.3747/co.v18i2.663
Shankar S, Ledakis P, El Halabi H, Gushchin V, Sardi A. Neoplasms of the appendix: current treatment guidelines. Hematol Oncol Clin North Am. 2012; 26(6): 1261–90. DOI: https://doi.org/10.1016/j.hoc.2012.08.010
Omohwo C, Nieroda CA, Studeman KD, Thieme H, Kostuik P, Ross AS, et al. Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology. J Am Coll Surg. 2009; 209(3): 308–12. DOI: https://doi.org/10.1016/j.jamcollsurg.2009.04.019
Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, et al. Long term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol. 2009; 16(7): 1903–11. DOI: https://doi.org/10.1245/s10434-009-0341-8
Youssef H, Newman C, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Operative findings, early complications, and long-term survival in 456 patients withPseudomyxoma peritoneisyndrome of appendiceal origin. Dis Colon Rectum. 2011; 54(3): 293–9. DOI: https://doi.org/10.1007/DCR.0b013e318202f026
El Halabi H, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, et al. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/ HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol. 2012; 19(1): 110–4. DOI: https://doi.org/10.1245/s10434-011-1840-y
Halabi HE, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, et al. Prognostic significance of lymph node metastasis in patients with high-grade appendiceal cancer. Ann Surg Oncol. 2012; 19(1): 122–5. DOI: https://doi.org/10.1245/s10434-011-1903-0
Zhu KJ, Morris DL. Primary peritonectomy/ HIPEC for disseminated peritoneal adenomucinosis achieves much lower recurrence rates and better survival than secondary procedures. Surgeon. 2009; 7(6): 345–50. DOI: https://doi.org/10.1016/S1479-666X(09)80108-X
Downloads
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use